Area of research
Infectious Diseases · Oncology
Research interest
Research interests include COVID-19 and healthcare impacts, COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, and Chronic Lymphocytic Leukemia Research.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLL
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
The evolving landscape of <scp>COVID</scp>‐19 and <scp>post‐COVID</scp> condition in patients with chronic lymphocytic leukemia: A study by <scp>ERIC</scp>, the <scp>European</scp> research initiative on <scp>CLL</scp>
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
UCL Discovery (University College London) 2022cited by 76position: middle
Outcome of infection with omicron <scp>SARS‐CoV</scp>‐2 variant in patients with hematological malignancies: An <scp>EPICOVIDEHA</scp> survey report
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
Real-World Evidence on Therapeutic Strategies and Treatment-Sequencing in Patients with Chronic Lymphocytic Leukemia: An International Study of Eric, the European Research Initiative on CLL